Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
ALT logo

ALT

NSD
Altimmune Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Thursday 10th July 2025
4.74
+0.16 (3.49%)
Prev Close:4.58
Open:4.59
Bid:4.72
Ask:4.74
52 Week Range
2.90
11.16
Volume:5,283,746
Mkt Cap:371 M
Price Target
$5.45
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

ALT - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Accrued Preferred Stock Dividends452925.03 M5 M368548.0
Depreciation And Amortization200000.0500000.0500000.0400000.0300000.0-239821.0-218717.0-83834.0-63109.0141604.0
Gain On Sale Of Security30000.0-3 M90384.0-957070.0299477.0
General And Administrative Expense21 M18 M17 M15 M13 M9 M10 M8 M7 M6 M
Gross Profit Margin (profit Margin After CGS)20000.0426000.0-68000.04 M8 M6 M10 M11 M3 M11 M
Impairment Of Capital Assets579000.01000000.025 M36 M
Interest Expense Non Operating35000.08000.05000.09421.02244.0297090.0162139.038499.054581.0
Misc Other Special Charges48000.0166000.0-32000.0-374000.024147.015139.0277886.05670.042303.08137.0
Net Income (loss)-95 M-88 M-85 M-97 M-49 M-21 M-39 M-46 M-11 M-3 M
Net Income Common Stockholders-95 M-88 M-85 M-97 M-49 M-21 M-42 M-51 M-11 M-3 M
Net Income Continuous Operations-95 M-88 M-85 M-97 M-49 M-21 M-39 M-46 M-11 M-3 M
Net Non Operating Interest Income Expense8 M7 M3 M198000.0313093.0871165.0-70493.0-114560.0-37452.0-229192.0
Net Operating Interest Income Expense168150.0-54581.0
Non Recurring Operation Expense-217 M
Normalized Income-94 M
Operating Income-103 M-96 M-88 M-97 M-55 M-20 M-18 M-16 M-11 M-856641.0
Operating Income Before Depreciation (EBITDA)-95 M-88 M-84 M-97 M-54 M-20 M-45 M-52 M-11 M-3 M
Operating Expense103 M96 M88 M101 M63 M-27 M-53 M-63 M-14 M-14 M
Other Gand A21 M18 M17 M15 M13 M9 M10 M8 M7 M6 M
Other Impairment Of Capital Assets12 M11 M-1000000.0-24 M-36981.0
Other Operating Expenses500000.0500000.0500000.0500000.0-710783.0
Otherunder Preferred Stock Dividend452925.03 M5 M368548.0
Preferred Stock Dividends452925.03 M5 M368548.0
Rent And Landing Fees407200.09 M10 M8 M7 M6 M
Research Expense82 M66 M71 M75 M50 M18 M18 M18 M7 M5 M
Restructring And Mn A Income-249643.03 M
Salaries And Wages14 M11 M8 M6 M3 M-1 M-773248.0-1 M-965365.0-613017.0
Total Income Available For Interest Expense (EBIT)-95 M-88 M-85 M-97 M-54 M-21 M-45 M-52 M-11 M-3 M
Total Revenues20000.0426000.0-68000.04 M8 M6 M10 M11 M3 M11 M
Total Expenses103 M96 M88 M101 M63 M-27 M-53 M-63 M-14 M-14 M
Total Revenue20000.0426000.0-68000.04 M8 M6 M10 M11 M3 M11 M
Amord12 M12 M13 M
Avgshs71 M53 M47 M41 M26 M13 M3 M426836.02 M2 M
Avgshsdt71 M53 M47 M41 M26 M13 M3 M385913.02 M2 M
Basiceps-1.34-1.66-1.81-2.35-1.9189.1-0.6
Basicepscont-1.34-1.66-1.81-2.35-1.91
Cor-100000.0
Depamor200000.0500000.0500000.0400000.0300000.0-239821.0-218717.0-83834.0-63109.0141604.0
Dileps-1.34-1.66-1.81-2.35-1.91-1.6-15.16-120.388.5-1.5
Dilepscont-1.34-1.66-1.81-2.35
Intinc8 M7 M3 M203000.0322514.0873409.0226597.047579.01047.0-229192.0
Netincdisc-95 M-88 M-85 M-97 M-49 M-21 M-39 M-46 M-11 M-3 M
Othincexp-48000.012 M-32000.012 M-24147.0-15139.02 M-96054.0-42303.0-307614.0
Pretaxinc-95 M-88 M-85 M-97 M-54 M-21 M-45 M-52 M-11 M-3 M
Resdev82 M66 M71 M75 M50 M18 M18 M18 M7 M5 M
Restruct-249643.03 M
Sga21 M18 M17 M15 M13 M9 M10 M8 M7 M6 M
Shsout77 M71 M49 M43 M37 M15 M13 M742369.0229383.0217504.0
Specincchg-579000.0-1000000.0-25 M-36 M217 M-3 M
Taxprov-197000.0-5 M-58500.0-6 M-6 M11 M61746.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader